News
If you’re pregnant or hoping to become pregnant, it’s natural to have questions about your medications. And if you’re taking ...
A study found jabs were linked to a 'modestly increased risk' of diabetic retinopathy-a condition caused by damage to blood ...
(HealthDay News) — For older adults with type 2 diabetes, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with nonarteritic anterior ischemic optic neuropathy (NAION), according ...
Obesity is a worldwide problem that is increasing. It also is associated with ocular problems. A recent study found that in addition to weight loss, the newer weight loss medications may provide ...
Severe pediatric obesity rates have increased exponentially over the past 15 years, according to a study published in JAMA ...
Over time, these drugs have also been found to help people lose weight by slowing digestion, reducing hunger, and making ...
China’s drugmakers are racing to roll out cheaper or more innovative alternatives. Read more at straitstimes.com. Read more ...
Tirzepatide (GIP + GLP-1) has also been shown to reduce cardiovascular risk. In an international trial of 713 adults in nine ...
15h
The Print on MSNBlockbuster semaglutide set to go off patent, Indian pharma sees a multi-billion-dollar opportunityPharma firms are pouncing on opportunity as patents on world’s second-bestselling drug, which goes by brand names Ozempic and ...
Doctors suggest that anybody with a Body mass index of over 30 or greater than 27 is advised to try weight loss drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results